๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Eli Lilly Nederland B.V. โ€” Licensed Medicines

98 medicines held by Eli Lilly Nederland B.V. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
โ† All medicines ยท 98 products held by Eli Lilly Nederland B.V.
MedicineActive substanceLicence holderStatus
Mounjaro 12.5 mg solution for injection in pre-filled pen
EU/1/22/1685/013-015
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 12.5 mg/dose KwikPen solution for injection in pre-filled pen
EU/1/22/1685/057-058
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 15 mg solution for injection in pre-filled pen
EU/1/22/1685/016-018
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 15 mg/dose KwikPen solution for injection in pre-filled pen
EU/1/22/1685/059-060
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 2.5 mg solution for injection in pre-filled pen
EU/1/22/1685/001-003
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 2.5 mg/dose KwikPen solution for injection in pre-filled pen
EU/1/22/1685/049-050
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 5 mg solution for injection in pre-filled pen
EU/1/22/1685/004-006
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 5 mg/dose KwikPen solution for injection in pre-filled pen
EU/1/22/1685/051-052
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 7.5 mg solution for injection in pre-filled pen
EU/1/22/1685/007-009
Tirzepatide Eli Lilly Nederland B.V. โ€”
Mounjaro 7.5 mg/dose KwikPen solution for injection in pre-filled pen
EU/1/22/1685/053-054
Tirzepatide Eli Lilly Nederland B.V. โ€”
Olumiant 1 mg film-coated tablets
EU/1/16/1170/017-019
Baricitinib Eli Lilly Nederland B.V. โ€”
Olumiant 2 mg film-coated tablets
EU/1/16/1170/001-008
Baricitinib Eli Lilly Nederland B.V. โ€”
Olumiant 4 mg film-coated tablets
EU/1/16/1170/009-016
Baricitinib Eli Lilly Nederland B.V. โ€”
Omvoh 100 mg solution for injection in pre-filled syringe
EU/1/23/1736/002-003
MIRIKIZUMAB Eli Lilly Nederland B.V. โ€”
Omvoh 100mg + 200mg solution for injection in pre-filled pen
EU/1/23/1736/009-010
MIRIKIZUMAB Eli Lilly Nederland B.V. โ€”
Omvoh 100mg +200mg solution for injection in pre-filled syringe
EU/1/23/1736/007-008
MIRIKIZUMAB Eli Lilly Nederland B.V. โ€”
Omvoh 100mg solution for injection in pre-filled pen
EU/1/23/1736/004-006
MIRIKIZUMAB Eli Lilly Nederland B.V. โ€”
Omvoh 300 mg concentrate for solution for infusion
EU/1/23/1736/001
MIRIKIZUMAB Eli Lilly Nederland B.V. โ€”
Optruma 60 mg film coated tablets
EU/1/98/074/001
Raloxifene Eli Lilly Nederland B.V. โ€”
Optruma 60 mg film coated tablets
EU/1/98/074/002
Raloxifene Eli Lilly Nederland B.V. โ€”
Optruma 60 mg film coated tablets
EU/1/98/074/003
Raloxifene Eli Lilly Nederland B.V. โ€”
Optruma 60 mg film coated tablets
EU/1/98/074/004
Raloxifene Eli Lilly Nederland B.V. โ€”
Pemetrexed Lilly
EU/1/15/1034/001
Pemetrexed disodium heptahydrate Eli Lilly Nederland B.V. โ€”
Pemetrexed Lilly
EU/1/15/1034/002
Pemetrexed disodium heptahydrate Eli Lilly Nederland B.V. โ€”
RAYVOW 100 mg film-coated tablets
EU/1/21/1587/011-020
Lasmiditan Succinate Eli Lilly Nederland B.V. โ€”
RAYVOW 200 mg film-coated tablets
EU/1/21/1587/021-030
Lasmiditan Succinate Eli Lilly Nederland B.V. โ€”
RAYVOW 50 mg film-coated tablets
EU/1/21/1587/001-010
Lasmiditan Succinate Eli Lilly Nederland B.V. โ€”
Retsevmo 120 mg film-coated tablets
EU/1/20/1527/018-020
Selpercatinib Eli Lilly Nederland B.V. โ€”
Retsevmo 160 mg film-coated tablets
EU/1/20/1527/021-023
Selpercatinib Eli Lilly Nederland B.V. โ€”
Retsevmo 40 mg film-coated tablets
EU/1/20/1527/012-014
Selpercatinib Eli Lilly Nederland B.V. โ€”
Retsevmo 40 mg hard capsules
EU/1/20/1527/001
Selpercatinib Eli Lilly Nederland B.V. โ€”
Retsevmo 80 mg film-coated tablets
EU/1/20/1527/015-017
Selpercatinib Eli Lilly Nederland B.V. โ€”
Retsevmo 80 mg hard capsules
EU/1/20/1527/002-003
Selpercatinib Eli Lilly Nederland B.V. โ€”
Strattera 4 mg/mL oral solution
PA2276/007/008
ATOMOXETINE Eli Lilly Nederland B.V. Not marketed
Tadalafil Lilly 10 mg film-coated tablets
EU/1/17/1177/005
Tadalafil Eli Lilly Nederland B.V. โ€”
Tadalafil Lilly 2.5 mg film-coated tablets
EU/1/17/1177/001
Tadalafil Eli Lilly Nederland B.V. โ€”
Tadalafil Lilly 20 mg film-coated tablets
EU/1/17/1177/006-009
Tadalafil Eli Lilly Nederland B.V. โ€”
Tadalafil Lilly 5 mg film-coated tablets
EU/1/17/1177/002-004
Tadalafil Eli Lilly Nederland B.V. โ€”
Tauvid 800 MBq/mL solution for injection
EU/1/24/1799/001
Flortaucipir (18F) Eli Lilly Nederland B.V. โ€”
Trulicity 0.75 mg Solution for injection
EU/1/14/956/001-005
Dulaglutide Eli Lilly Nederland B.V. โ€”
Trulicity 1.5 mg Solution for injection
EU/1/14/956/006-010
Dulaglutide Eli Lilly Nederland B.V. โ€”
Trulicity 3 mg Solution for injection
EU/1/14/956/011-0013
Dulaglutide Eli Lilly Nederland B.V. โ€”
Trulicity 4.5 mg Solution for injection
EU/1/14/956/014-0016
Dulaglutide Eli Lilly Nederland B.V. โ€”
Verzenios 100 mg Film-coated tablet
EU/1/18/1307/004-006
ABEMACICLIB Eli Lilly Nederland B.V. โ€”
Verzenios 150 mg Film-coated tablet
EU/1/18/1307/007-009
ABEMACICLIB Eli Lilly Nederland B.V. โ€”
Verzenios 50 mg Film-coated tablet
EU/1/18/1307/001-003
ABEMACICLIB Eli Lilly Nederland B.V. โ€”
Yentreve
EU/1/04/280/1-6
Duloxetine hydrochloride Eli Lilly Nederland B.V. โ€”
Yentreve 20 mg hard gastro-resistant capsules
EU/1/04/280/001
Duloxetine hydrochloride Eli Lilly Nederland B.V. โ€”
โ† 1 2

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.